Genmab A/S |
Date/Time | / |
Chg. / Chg.(%) | - / |
Bid | - |
Ask | - |
Open | - |
Previous Close | - |
High | - |
Low | - |
Volume [DKK] | - |
Volume [Units] | |
Price fixings | |
ISIN | DK0010272202 |
Security | GMAB |
Exchange | OMX Nordic |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Cboe Europe .. | 2,526.50 | ![]() |
46,606 |
Turquoise | 2,527.00 | ![]() |
8,628 |
London Inter.. | 2,528.0 | ![]() |
6,450 |
Cboe Europe .. | 2,528.00 | ![]() |
148 |
Nasdaq Other.. | 367.7400 | ![]() |
121 |
TradeGate | 341.800 | ![]() |
11 |
gettex | 337.000 | ![]() |
1 |
Vienna Globa.. | 338.40 | ![]() |
0 |
München | 340.00 | ![]() |
0 |
Düsseldorf | 336.20 | ![]() |
0 |
Hannover | 338.60 | ![]() |
0 |
Frankfurt | 339.6000 | ![]() |
0 |
Berlin | 337.40 | ![]() |
0 |
Quotrix | 341.0000 | ![]() |
|
Lang & Schwa.. | 335.50 | ![]() |
|
Stuttgart | 340.000 | ![]() |
|
OMX Nordic | 2,547.00 | ![]() |
87,169 |
Cboe Europe .. | 2,550.00 | 4 |
News
- Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
03/15/2022 / 23:00 - GlobeNewswire - BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLC
03/08/2022 / 14:27 - GlobeNewswire - Notice to Convene the Annual General Meeting of Genmab A/S
02/24/2022 / 12:01 - GlobeNewswire - PTA-News: Medigene AG: BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
02/21/2022 / 19:25 - pressetext - BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer
02/21/2022 / 19:25 - GlobeNewswire